Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Ophthalmic Antivirals Market Research Report 2025

Global Ophthalmic Antivirals Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 85 Pages

Report ld: 3453321

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Ophthalmic Antivirals was valued at US$ 621 million in the year 2024 and is projected to reach a revised size of US$ 1063 million by 2031, growing at a CAGR of 8.1% during the forecast period.

Antiviral medications are used to treat infections caused by viruses. They stop viruses from spreading or multiplying. Eye ointment or drops are used to treat simple viral eye infections.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Antivirals.

The Ophthalmic Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ophthalmic Antivirals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Novartis

Allergan

Valeant Pharmaceuticals

Santen Pharmaceutical

Lupin Pharmaceuticals

Apotex

Akorn

Fera Pharmaceuticals

Shenyang Xingqi Pharma

Segment by Type

Solutions

Suspensions

Gels or Ointments

Segment by Application

Hospital

Pharmacy

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Ophthalmic Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Ophthalmic Antivirals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Ophthalmic Antivirals Market Overview

1.1 Product Definition

1.2 Ophthalmic Antivirals by Type

1.2.1 Global Ophthalmic Antivirals Market Value Comparison by Type (2024 VS 2031)

1.2.2 Solutions

1.2.3 Suspensions

1.2.4 Gels or Ointments

1.3 Ophthalmic Antivirals by Application

1.3.1 Global Ophthalmic Antivirals Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Global Ophthalmic Antivirals Market Size Estimates and Forecasts

1.4.1 Global Ophthalmic Antivirals Revenue 2020-2031

1.4.2 Global Ophthalmic Antivirals Sales 2020-2031

1.4.3 Global Ophthalmic Antivirals Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Ophthalmic Antivirals Market Competition by Manufacturers

2.1 Global Ophthalmic Antivirals Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ophthalmic Antivirals Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ophthalmic Antivirals Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ophthalmic Antivirals, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ophthalmic Antivirals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ophthalmic Antivirals, Product Type & Application

2.7 Global Key Manufacturers of Ophthalmic Antivirals, Date of Enter into This Industry

2.8 Global Ophthalmic Antivirals Market Competitive Situation and Trends

2.8.1 Global Ophthalmic Antivirals Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ophthalmic Antivirals Players Market Share by Revenue

2.8.3 Global Ophthalmic Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ophthalmic Antivirals Market Scenario by Region

3.1 Global Ophthalmic Antivirals Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ophthalmic Antivirals Sales by Region: 2020-2031

3.2.1 Global Ophthalmic Antivirals Sales by Region: 2020-2025

3.2.2 Global Ophthalmic Antivirals Sales by Region: 2026-2031

3.3 Global Ophthalmic Antivirals Revenue by Region: 2020-2031

3.3.1 Global Ophthalmic Antivirals Revenue by Region: 2020-2025

3.3.2 Global Ophthalmic Antivirals Revenue by Region: 2026-2031

3.4 North America Ophthalmic Antivirals Market Facts & Figures by Country

3.4.1 North America Ophthalmic Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ophthalmic Antivirals Sales by Country (2020-2031)

3.4.3 North America Ophthalmic Antivirals Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ophthalmic Antivirals Market Facts & Figures by Country

3.5.1 Europe Ophthalmic Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ophthalmic Antivirals Sales by Country (2020-2031)

3.5.3 Europe Ophthalmic Antivirals Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ophthalmic Antivirals Market Facts & Figures by Region

3.6.1 Asia Pacific Ophthalmic Antivirals Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ophthalmic Antivirals Sales by Region (2020-2031)

3.6.3 Asia Pacific Ophthalmic Antivirals Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ophthalmic Antivirals Market Facts & Figures by Country

3.7.1 Latin America Ophthalmic Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ophthalmic Antivirals Sales by Country (2020-2031)

3.7.3 Latin America Ophthalmic Antivirals Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ophthalmic Antivirals Market Facts & Figures by Country

3.8.1 Middle East and Africa Ophthalmic Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ophthalmic Antivirals Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ophthalmic Antivirals Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Ophthalmic Antivirals Sales by Type (2020-2031)

4.1.1 Global Ophthalmic Antivirals Sales by Type (2020-2025)

4.1.2 Global Ophthalmic Antivirals Sales by Type (2026-2031)

4.1.3 Global Ophthalmic Antivirals Sales Market Share by Type (2020-2031)

4.2 Global Ophthalmic Antivirals Revenue by Type (2020-2031)

4.2.1 Global Ophthalmic Antivirals Revenue by Type (2020-2025)

4.2.2 Global Ophthalmic Antivirals Revenue by Type (2026-2031)

4.2.3 Global Ophthalmic Antivirals Revenue Market Share by Type (2020-2031)

4.3 Global Ophthalmic Antivirals Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ophthalmic Antivirals Sales by Application (2020-2031)

5.1.1 Global Ophthalmic Antivirals Sales by Application (2020-2025)

5.1.2 Global Ophthalmic Antivirals Sales by Application (2026-2031)

5.1.3 Global Ophthalmic Antivirals Sales Market Share by Application (2020-2031)

5.2 Global Ophthalmic Antivirals Revenue by Application (2020-2031)

5.2.1 Global Ophthalmic Antivirals Revenue by Application (2020-2025)

5.2.2 Global Ophthalmic Antivirals Revenue by Application (2026-2031)

5.2.3 Global Ophthalmic Antivirals Revenue Market Share by Application (2020-2031)

5.3 Global Ophthalmic Antivirals Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Ophthalmic Antivirals Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Company Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Allergan Ophthalmic Antivirals Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Valeant Pharmaceuticals

6.3.1 Valeant Pharmaceuticals Company Information

6.3.2 Valeant Pharmaceuticals Description and Business Overview

6.3.3 Valeant Pharmaceuticals Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Valeant Pharmaceuticals Ophthalmic Antivirals Product Portfolio

6.3.5 Valeant Pharmaceuticals Recent Developments/Updates

6.4 Santen Pharmaceutical

6.4.1 Santen Pharmaceutical Company Information

6.4.2 Santen Pharmaceutical Description and Business Overview

6.4.3 Santen Pharmaceutical Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Santen Pharmaceutical Ophthalmic Antivirals Product Portfolio

6.4.5 Santen Pharmaceutical Recent Developments/Updates

6.5 Lupin Pharmaceuticals

6.5.1 Lupin Pharmaceuticals Company Information

6.5.2 Lupin Pharmaceuticals Description and Business Overview

6.5.3 Lupin Pharmaceuticals Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lupin Pharmaceuticals Ophthalmic Antivirals Product Portfolio

6.5.5 Lupin Pharmaceuticals Recent Developments/Updates

6.6 Apotex

6.6.1 Apotex Company Information

6.6.2 Apotex Description and Business Overview

6.6.3 Apotex Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Apotex Ophthalmic Antivirals Product Portfolio

6.6.5 Apotex Recent Developments/Updates

6.7 Akorn

6.7.1 Akorn Company Information

6.7.2 Akorn Description and Business Overview

6.7.3 Akorn Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Akorn Ophthalmic Antivirals Product Portfolio

6.7.5 Akorn Recent Developments/Updates

6.8 Fera Pharmaceuticals

6.8.1 Fera Pharmaceuticals Company Information

6.8.2 Fera Pharmaceuticals Description and Business Overview

6.8.3 Fera Pharmaceuticals Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Fera Pharmaceuticals Ophthalmic Antivirals Product Portfolio

6.8.5 Fera Pharmaceuticals Recent Developments/Updates

6.9 Shenyang Xingqi Pharma

6.9.1 Shenyang Xingqi Pharma Company Information

6.9.2 Shenyang Xingqi Pharma Description and Business Overview

6.9.3 Shenyang Xingqi Pharma Ophthalmic Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shenyang Xingqi Pharma Ophthalmic Antivirals Product Portfolio

6.9.5 Shenyang Xingqi Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ophthalmic Antivirals Industry Chain Analysis

7.2 Ophthalmic Antivirals Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ophthalmic Antivirals Production Mode & Process Analysis

7.4 Ophthalmic Antivirals Sales and Marketing

7.4.1 Ophthalmic Antivirals Sales Channels

7.4.2 Ophthalmic Antivirals Distributors

7.5 Ophthalmic Antivirals Customer Analysis

8 Ophthalmic Antivirals Market Dynamics

8.1 Ophthalmic Antivirals Industry Trends

8.2 Ophthalmic Antivirals Market Drivers

8.3 Ophthalmic Antivirals Market Challenges

8.4 Ophthalmic Antivirals Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Ophthalmic Antivirals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ophthalmic Antivirals Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Ophthalmic Antivirals Market Competitive Situation by Manufacturers in 2024

Table 4. Global Ophthalmic Antivirals Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Ophthalmic Antivirals Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Ophthalmic Antivirals Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Ophthalmic Antivirals Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Ophthalmic Antivirals Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Ophthalmic Antivirals, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ophthalmic Antivirals, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ophthalmic Antivirals, Product Type & Application

Table 12. Global Key Manufacturers of Ophthalmic Antivirals, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ophthalmic Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Antivirals as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ophthalmic Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Ophthalmic Antivirals Sales by Region (2020-2025) & (K Units)

Table 18. Global Ophthalmic Antivirals Sales Market Share by Region (2020-2025)

Table 19. Global Ophthalmic Antivirals Sales by Region (2026-2031) & (K Units)

Table 20. Global Ophthalmic Antivirals Sales Market Share by Region (2026-2031)

Table 21. Global Ophthalmic Antivirals Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Ophthalmic Antivirals Revenue Market Share by Region (2020-2025)

Table 23. Global Ophthalmic Antivirals Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Ophthalmic Antivirals Revenue Market Share by Region (2026-2031)

Table 25. North America Ophthalmic Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Ophthalmic Antivirals Sales by Country (2020-2025) & (K Units)

Table 27. North America Ophthalmic Antivirals Sales by Country (2026-2031) & (K Units)

Table 28. North America Ophthalmic Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Ophthalmic Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Ophthalmic Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Ophthalmic Antivirals Sales by Country (2020-2025) & (K Units)

Table 32. Europe Ophthalmic Antivirals Sales by Country (2026-2031) & (K Units)

Table 33. Europe Ophthalmic Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Ophthalmic Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Ophthalmic Antivirals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Ophthalmic Antivirals Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Ophthalmic Antivirals Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Ophthalmic Antivirals Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Ophthalmic Antivirals Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ophthalmic Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Ophthalmic Antivirals Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Ophthalmic Antivirals Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Ophthalmic Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Ophthalmic Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Ophthalmic Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Ophthalmic Antivirals Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Ophthalmic Antivirals Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Ophthalmic Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Ophthalmic Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Ophthalmic Antivirals Sales (K Units) by Type (2020-2025)

Table 51. Global Ophthalmic Antivirals Sales (K Units) by Type (2026-2031)

Table 52. Global Ophthalmic Antivirals Sales Market Share by Type (2020-2025)

Table 53. Global Ophthalmic Antivirals Sales Market Share by Type (2026-2031)

Table 54. Global Ophthalmic Antivirals Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Ophthalmic Antivirals Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Ophthalmic Antivirals Revenue Market Share by Type (2020-2025)

Table 57. Global Ophthalmic Antivirals Revenue Market Share by Type (2026-2031)

Table 58. Global Ophthalmic Antivirals Price (US$/Unit) by Type (2020-2025)

Table 59. Global Ophthalmic Antivirals Price (US$/Unit) by Type (2026-2031)

Table 60. Global Ophthalmic Antivirals Sales (K Units) by Application (2020-2025)

Table 61. Global Ophthalmic Antivirals Sales (K Units) by Application (2026-2031)

Table 62. Global Ophthalmic Antivirals Sales Market Share by Application (2020-2025)

Table 63. Global Ophthalmic Antivirals Sales Market Share by Application (2026-2031)

Table 64. Global Ophthalmic Antivirals Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Ophthalmic Antivirals Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Ophthalmic Antivirals Revenue Market Share by Application (2020-2025)

Table 67. Global Ophthalmic Antivirals Revenue Market Share by Application (2026-2031)

Table 68. Global Ophthalmic Antivirals Price (US$/Unit) by Application (2020-2025)

Table 69. Global Ophthalmic Antivirals Price (US$/Unit) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Novartis Ophthalmic Antivirals Product

Table 74. Novartis Recent Developments/Updates

Table 75. Allergan Company Information

Table 76. Allergan Description and Business Overview

Table 77. Allergan Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Allergan Ophthalmic Antivirals Product

Table 79. Allergan Recent Developments/Updates

Table 80. Valeant Pharmaceuticals Company Information

Table 81. Valeant Pharmaceuticals Description and Business Overview

Table 82. Valeant Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Valeant Pharmaceuticals Ophthalmic Antivirals Product

Table 84. Valeant Pharmaceuticals Recent Developments/Updates

Table 85. Santen Pharmaceutical Company Information

Table 86. Santen Pharmaceutical Description and Business Overview

Table 87. Santen Pharmaceutical Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Santen Pharmaceutical Ophthalmic Antivirals Product

Table 89. Santen Pharmaceutical Recent Developments/Updates

Table 90. Lupin Pharmaceuticals Company Information

Table 91. Lupin Pharmaceuticals Description and Business Overview

Table 92. Lupin Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Lupin Pharmaceuticals Ophthalmic Antivirals Product

Table 94. Lupin Pharmaceuticals Recent Developments/Updates

Table 95. Apotex Company Information

Table 96. Apotex Description and Business Overview

Table 97. Apotex Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Apotex Ophthalmic Antivirals Product

Table 99. Apotex Recent Developments/Updates

Table 100. Akorn Company Information

Table 101. Akorn Description and Business Overview

Table 102. Akorn Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Akorn Ophthalmic Antivirals Product

Table 104. Akorn Recent Developments/Updates

Table 105. Fera Pharmaceuticals Company Information

Table 106. Fera Pharmaceuticals Description and Business Overview

Table 107. Fera Pharmaceuticals Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Fera Pharmaceuticals Ophthalmic Antivirals Product

Table 109. Fera Pharmaceuticals Recent Developments/Updates

Table 110. Shenyang Xingqi Pharma Company Information

Table 111. Shenyang Xingqi Pharma Description and Business Overview

Table 112. Shenyang Xingqi Pharma Ophthalmic Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Shenyang Xingqi Pharma Ophthalmic Antivirals Product

Table 114. Shenyang Xingqi Pharma Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Ophthalmic Antivirals Distributors List

Table 118. Ophthalmic Antivirals Customers List

Table 119. Ophthalmic Antivirals Market Trends

Table 120. Ophthalmic Antivirals Market Drivers

Table 121. Ophthalmic Antivirals Market Challenges

Table 122. Ophthalmic Antivirals Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ophthalmic Antivirals

Figure 2. Global Ophthalmic Antivirals Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ophthalmic Antivirals Market Share by Type: 2024 & 2031

Figure 4. Solutions Product Picture

Figure 5. Suspensions Product Picture

Figure 6. Gels or Ointments Product Picture

Figure 7. Global Ophthalmic Antivirals Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Ophthalmic Antivirals Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Others

Figure 12. Global Ophthalmic Antivirals Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Ophthalmic Antivirals Market Size (2020-2031) & (US$ Million)

Figure 14. Global Ophthalmic Antivirals Sales (2020-2031) & (K Units)

Figure 15. Global Ophthalmic Antivirals Average Price (US$/Unit) & (2020-2031)

Figure 16. Ophthalmic Antivirals Report Years Considered

Figure 17. Ophthalmic Antivirals Sales Share by Manufacturers in 2024

Figure 18. Global Ophthalmic Antivirals Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Ophthalmic Antivirals Players: Market Share by Revenue in Ophthalmic Antivirals in 2024

Figure 20. Ophthalmic Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Ophthalmic Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Ophthalmic Antivirals Sales Market Share by Country (2020-2031)

Figure 23. North America Ophthalmic Antivirals Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Ophthalmic Antivirals Sales Market Share by Country (2020-2031)

Figure 27. Europe Ophthalmic Antivirals Revenue Market Share by Country (2020-2031)

Figure 28. Germany Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Ophthalmic Antivirals Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Ophthalmic Antivirals Revenue Market Share by Region (2020-2031)

Figure 35. China Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Ophthalmic Antivirals Sales Market Share by Country (2020-2031)

Figure 46. Latin America Ophthalmic Antivirals Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Ophthalmic Antivirals Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Ophthalmic Antivirals Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Ophthalmic Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Ophthalmic Antivirals by Type (2020-2031)

Figure 56. Global Revenue Market Share of Ophthalmic Antivirals by Type (2020-2031)

Figure 57. Global Ophthalmic Antivirals Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Ophthalmic Antivirals by Application (2020-2031)

Figure 59. Global Revenue Market Share of Ophthalmic Antivirals by Application (2020-2031)

Figure 60. Global Ophthalmic Antivirals Price (US$/Unit) by Application (2020-2031)

Figure 61. Ophthalmic Antivirals Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Ophthalmic Antivirals market? zhanKai

The top companies in the global Ophthalmic Antivirals market are Novartis、Allergan、Valeant Pharmaceuticals.

What is the annual compound growth rate of the global Ophthalmic Antivirals market size from 2025 to 2031? shouQi

What was the global market size of Ophthalmic Antivirals in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Ophthalmic Antivirals Market Insights, Forecast to 2030
Antiviral medications are used to treat infections caused by viruses. They stop viruses from spreading or multiplying. Eye ointment or drops are used to treat simple viral eye infections.
Published Date: 2024-04-12
Pages: 93
USD 4900.00
(Single User License)

Global Ophthalmic Antivirals Market Insights, Forecast to 2030
Antiviral medications are used to treat infections caused by viruses. They stop viruses from spreading or multiplying. Eye ointment or drops are used to treat simple viral eye infections.
Published: 2024-04-12
Pages: 93
USD 4900.00 (Single User License)